NCT05159752 2023-06-18A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)Clinuvel Pharmaceuticals LimitedPhase 2 Unknown6 enrolled
NCT04155190 2023-05-31An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCCSol-Gel Technologies, Ltd.Phase 2 Terminated47 enrolled